- Home
- ADIL vs UPC Comparison
ADIL vs UPC Comparison
Compare ADIL & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADIL
- UPC
- Stock Information
- Founded
- ADIL 2010
- UPC 1998
- Country
- ADIL United States
- UPC China
- Employees
- ADIL N/A
- UPC N/A
- Industry
- ADIL Biotechnology: Pharmaceutical Preparations
- UPC Biotechnology: Pharmaceutical Preparations
- Sector
- ADIL Health Care
- UPC Health Care
- Exchange
- ADIL Nasdaq
- UPC Nasdaq
- Market Cap
- ADIL 6.5M
- UPC 6.6M
- IPO Year
- ADIL 2018
- UPC 2021
- Fundamental
- Price
- ADIL $1.06
- UPC $0.14
- Analyst Decision
- ADIL Strong Buy
- UPC
- Analyst Count
- ADIL 1
- UPC 0
- Target Price
- ADIL $8.00
- UPC N/A
- AVG Volume (30 Days)
- ADIL 222.2K
- UPC 803.8K
- Earning Date
- ADIL 11-13-2024
- UPC 01-01-0001
- Dividend Yield
- ADIL N/A
- UPC N/A
- EPS Growth
- ADIL N/A
- UPC N/A
- EPS
- ADIL N/A
- UPC N/A
- Revenue
- ADIL N/A
- UPC $26,725,919.00
- Revenue This Year
- ADIL N/A
- UPC N/A
- Revenue Next Year
- ADIL N/A
- UPC N/A
- P/E Ratio
- ADIL N/A
- UPC N/A
- Revenue Growth
- ADIL N/A
- UPC N/A
- 52 Week Low
- ADIL $0.77
- UPC $0.12
- 52 Week High
- ADIL $4.17
- UPC $4.32
- Technical
- Relative Strength Index (RSI)
- ADIL 52.82
- UPC 20.65
- Support Level
- ADIL $0.98
- UPC $0.22
- Resistance Level
- ADIL $1.28
- UPC $0.29
- Average True Range (ATR)
- ADIL 0.07
- UPC 0.03
- MACD
- ADIL 0.00
- UPC 0.02
- Stochastic Oscillator
- ADIL 29.03
- UPC 10.30
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
About UPC Universe Pharmaceuticals Inc.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.